Assessment of regional myocardial oxygenation changes in the presence of coronary artery stenosis with balanced SSFP imaging at 3.0T: Theory and experimental evaluation in canines

Journal of Magnetic Resonance Imaging

Volumn 27, Issue 5, 2008, Pages 1037-1045

  Dharmakumar, Rohan ^a,c   Arumana, Jain Mangalathu ^a   Tang, Richard ^a   Harris, Kathleen ^a   Zhang, Zhouli ^a   Li, Debiao ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

3T; Blood; BOLD MRI; Coronary artery disease; Oxygen; SSFP

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; DOG; EXPERIMENTAL MODEL; HEART MUSCLE OXYGEN CONSUMPTION; IMAGE QUALITY; IMAGING SYSTEM; NONHUMAN; OXYGEN BLOOD LEVEL; PRIORITY JOURNAL; SIMULATION; STEADY STATE; THEORETICAL MODEL; VASODILATATION;

ANIMALS; COMPUTER SIMULATION; CORONARY STENOSIS; DOGS; FEASIBILITY STUDIES; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; OXYGEN;

EID: 42949174533     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21345     Document Type: Article

References (43)

1. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-171.
2. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96:793-800.
3. Mickleborough LL, Maruyama H, Takagi Y, Mohamed S, Sun Z, Ebisuzaki L. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995;92(Suppl):II73-II79.
4. Vanoverschelde JL, Gerber B, Pasquet A, Melin JA. Nuclear and echocardiographic imaging for prediction of reversible left ventricular ischemic dysfunction after coronary revascularization: current status and future directions. J Cardiovasc Pharmacol 1996;28(Suppl 1):S27-S36.
5. Clark AN, Beller GA. The present role of nuclear cardiology in clinical practice. Q J Nucl Med Mol Imaging 2005;49:43-58.
6. Klocke FJ. Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care. Circulation 1987;76:1183-1189.
7. Wilke N, Simm C, Zhang J, et al. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 1993;29:485-497.
8. Arai AE. Magnetic resonance first-pass myocardial perfusion imaging. Top Magn Reson Imaging 2000;11:383-398.
9. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17:2359-2362.
10. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242:647-649.
11. Brown JH, Hunt LP, Vites NP, Short CD, Gokal R, Mallick NP. Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994;9:1136-1142.
12. Gradaus F, Ivens K, Peters AJ, et al. Angiographic progression of coronary artery disease in patients with end-stage renal disease. Nephrol Dial Transplant 2001;16:1198-1202.
13. Thulborn KR, Waterton JC, Matthews PM, Radda GK. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta 1982;714:265-270.
14. Wright GA, Hu BS, Macovski A. 1991 I.I. Rabi Award. Estimating oxygen saturation of blood in vivo with MR imaging at 1.5 T. J Magn Reson Imaging 1991;1:275-283.
15. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995;34:555-566.
16. 2*: a theoretical approach for the vasculature of myocardium. Magn Reson Med 1999;42:1004-1010.
17. Atalay MK, Forder JR, Chacko VP, Kawamoto S, Zerhouni EA. Oxygenation in the rabbit myocardium: assessment with susceptibility-dependent MR imaging. Radiology 1993;189:759-764.
18. Li D, Dhawale P, Rubin PJ, Haacke EM, Gropler RJ. Myocardial signal response to dipyridamole and dobutamine: demonstration of the BOLD effect using a double-echo gradient-echo sequence. Magn Reson Med 1996;36:16-20.
19. Beache GM, Herzka DA, Boxerman JL, et al. Attenuated myocardial vasodilator response in patients with hypertensive hypertrophy revealed by oxygenation-dependent magnetic resonance imaging. Circulation 2001;104:1214-1217.
20. Foltz WD, Huang H, Fort S, Wright GA. Vasodilator response assessment in porcine myocardium with magnetic resonance relaxometry. Circulation 2002;106:2714-2719.
21. Wacker CM, Hartlep AW, Pfleger S, Schad LR, Ertl G, Bauer WR. Susceptibility-sensitive magnetic resonance imaging detects human myocardium supplied by a stenotic coronary artery without a contrast agent. J Am Coll Cardiol 2003;41:834-840.
22. Friedrich MG, Niendorf T, Schulz-Menger J, Gross CM, Dietz R. Blood oxygen level-dependent magnetic resonance imaging in patients with stress-induced angina. Circulation 2003;108:2219-2223.
23. 2-prepared steady-state free-precession magnetic resonance imaging. Circulation 2004;110:1284-1290.
24. 2-prepared steady-state free precession blood oxygen level-dependent MR imaging of myocardial perfusion in a dog stenosis model. Radiology 2005;236:503-509.
25. Dharmakumar R, Arumana JM, Larson AC, Chung Y, Wright GA, Li D. Cardiac phase-resolved blood oxygen-sensitive steady-state free precession MRI for evaluating the functional significance of coronary artery stenosis. Invest Radiol 2007;42:180-188.
26. Li D, Oellerich WF, Gropler RJ. Magnetic resonance assessment of myocardial oxygenation. In: Manning W, Pennell DJ, editors. Cardiovascular magnetic resonance. Philadelphia, PA: Churchill Livingstone; 2001. p 447-454.
27. 2* and field inhomogeneity maps in the human heart at 1.5 T. Magn Reson Med 1998;39:988-998.
28. 2-weighted 3D BOLD imaging. Magn Reson Med 2001;46:573-578.
29. 2 relaxation. Magn Reson Med 2003;49:1089-1097.
30. Dharmakumar R, Hong J, Brittain JH, Plewes DB, Wright GA. Oxygen-sensitive contrast in blood for steady-state free precession imaging. Magn Reson Med 2005;53:574-583.
31. Dharmakumar R, Qi X, Hong J, Wright GA. Detecting microcirculatory changes in blood oxygen state with steady-state free precession imaging. Magn Reson Med 2006;55:1372-1380.
32. Yang Y, Wen H, Mattay VS, Balaban RS, Frank JA, Duyn JH. Comparison of 3D BOLD functional MRI with spiral acquisition at 1.5 and 4.0 T. Neuroimage 1999;9:446-451.
33. Duong TQ, Yacoub E, Adriany G, Hu X, Ugurbil K, Kim SG. Microvascular BOLD contribution at 4 and 7 T in the human brain: gradient-echo and spin-echo fMRI with suppression of blood effects. Magn Reson Med 2003;49:1019-1027.
34. Klocke FJ, Simonetti OP, Judd RM, et al. Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging. Circulation 2001;104:2412-2416.
35. Schar M, Kozerke S, Fischer SE, Boesiger P. Cardiac SSFP imaging at 3 Tesla. Magn Reson Med 2004;51:799-806.
36. Lauerma K, Virtanen KS, Sipila LM, Hekali P, Aronen HJ. Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization. Circulation 1997;96:2859-2867.
37. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
38. Glenny RW, Bernard S, Brinkley M. Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion. J Appl Physiol 1993;74:2585-2597.
39. Mangalathu Arumana J, Li D, Dharmakumar R. The influence of imaging parameters on SSFP-based microcirculatory Blood-Oxygen-Level Dependent (BOLD) contrast: theory and experiment. ISMRM 2007; Berlin, Germany. p 3790.
40. 2 in the capillary network of myocardium. Magn Reson Med 1999;41:51-62.
41. Kennan RP, Zhong J, Gore JC. Intravascular susceptibility contrast mechanisms in tissues. Magn Reson Med 1994;31:9-21.
42. Kassab GS, Fung YC. Topology and dimensions of pig coronary capillary network. Am J Physiol 1994;267(Pt 2):H319-325.
43. 1 contrast agents: accuracy, precision, and water exchange. Magn Reson Med 1996;36:858-867.